Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

Application of operational tolerance signatures are limited by variability and type of immunosuppression in renal transplant recipients: A cross-sectional study.

<h4>Background</h4> <p>Renal transplant recipients (RTR) frequently develop complications relating to chronic immunosuppression. Identifying RTR who could safely reduce immunosuppression is therefore highly desirable. We hypothesized that “signatures” described in RTR who have sto...

Descripció completa

Dades bibliogràfiques
Autors principals:	Bottomley, M, Chen, M, Fuggle, S, Harden, P, Wood, K
Format:	Journal article
Idioma:	English
Publicat:	Lippincott, Williams and Wilkins 2016

Ítems similars

Defining a Methylation Signature Associated With Operational Tolerance in Kidney Transplant Recipients
per: Ramon M. Rodriguez, et al.
Publicat: (2021-08-01)

Update on the long-term complications of renal transplantation.
per: Bottomley, M, et al.
Publicat: (2013)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and associates with malignancy risk in long-term renal transplant recipients
per: Bottomley, M, et al.
Publicat: (2022)

Immunological risk stratification and tailored minimisation of immunosuppression in renal transplant recipients
per: Mysore K. Phanish, et al.
Publicat: (2020-03-01)

The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy.
per: Bittar, A, et al.
Publicat: (1990)

Dampened inflammatory signalling and myeloid-derived suppressor-like cell accumulation reduces circulating monocytic HLA-DR density and may associate with malignancy risk in long-term renal transplant recipients
per: Bottomley, MJ, et al.
Publicat: (2022)

Evaluation of the XM-ONE assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
per: Procter, J, et al.
Publicat: (2009)

Fatal complications of long-term immunosuppressive therapy in a renal transplant recipient
per: I G Rekhtina, et al.
Publicat: (2008-07-01)

Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
per: Matthew J. Bottomley, et al.
Publicat: (2022-07-01)

Comparative analysis of induction immunosuppressive therapy protocols in renal transplant recipients (retrospective review)
per: Sh. R. Galeev, et al.
Publicat: (2020-07-01)

Evaluation of the XM-ONE (R) assay and the role of endothelial cell antibodies in recipients of living donor renal transplants
per: Procter, J, et al.
Publicat: (2009)

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.
per: Ratcliffe, P, et al.
Publicat: (1996)

Determinants of immunosuppressive therapy in renal transplant recipients: an Italian observational study (the CESIT project)
per: Alessandro C. Rosa, et al.
Publicat: (2023-10-01)

Laryngeal cryptococcosis; a condition reported in renal transplant recipients and other immunosuppressed patients
per: Alfonso J. Rodriguez-Morales, et al.
Publicat: (2017-04-01)

The utilisation of biomarkers of a reduced immune response to predict squamous cell carcinoma in long-term renal transplant recipients
per: Bottomley, M
Publicat: (2015)

BK Virus in Kidney Transplant Recipients: The Influence of Immunosuppression
per: Katherine A. Barraclough, et al.
Publicat: (2011-01-01)

Prevalence of nonmalignant cutaneous disease in renal transplant recipients
per: Lally, A, et al.
Publicat: (2006)

Comparison of glucose tolerance in renal transplant recipients and hemodialysis patients
per: Rahbaninobar Mohammad, et al.
Publicat: (2004-09-01)

The Clinical Manifestation of Immunosuppressive Therapy as a Tool to Improve Immune Monitoring in Renal Transplant Recipients
per: Noa Scott, et al.
Publicat: (2023-05-01)

Oxidative and nitrosative stress in stable renal transplant recipients with respect to the immunosuppression protocol: Differences or similarities?
per: Cvetković Tatjana, et al.
Publicat: (2015-01-01)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
per: Muduma G, et al.
Publicat: (2014-11-01)

Successful Late Conversion to Mycophenolate Mofetil and Prednisone Immunosuppression Therapy in a Renal Transplant Recipient
per: Iqbal A, et al.
Publicat: (2000-01-01)

Interdyscyplinary management of verrucous carcinoma in renal transplant recipient on long term immunosuppression. Clinical report.
per: Jacek Pliszczynski, et al.
Publicat: (2020-09-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
per: Brook, MO, et al.
Publicat: (2022)

Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy
per: Sofia Christakoudi, et al.
Publicat: (2020-08-01)

Immunosuppression after the diagnosis of renal allograft renal cell carcinoma in two transplant recipients: Case reports and review of the literature
per: Joyita Bharati, et al.
Publicat: (2021-01-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
per: Koen G. A. M. Hussaarts, et al.
Publicat: (2021-01-01)

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus?
per: Knight, S, et al.
Publicat: (2016)

Evidence for the Immunosuppressive Potential of Calcineurin Inhibitor-Sparing Regimens in Liver Transplant Recipients with Impaired Renal Function
per: Kentaro Ide, et al.
Publicat: (2011-01-01)

Identification of Immunosuppressive Medication Nonadherence Factors Through a Combined Theory Model in Renal Transplant Recipients
per: Pengpeng Zhang, et al.
Publicat: (2021-05-01)

Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection
per: Amitabh Jha, et al.
Publicat: (2018-01-01)

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients
per: Susan Dutton, et al.
Publicat: (2022-04-01)

Impacts on Donor-Recipient HLA Matching on Operational Tolerance Following Pediatric Living-Donor Liver Transplantation
per: Ohe, H, et al.
Publicat: (2011)

A national survey of immunosuppression adjustment in elderly lung transplant recipients
per: Jade M Kozuch, et al.
Publicat: (2024-12-01)

Rapid Development of Syringocystadenocarcinoma Papilliferum in an Immunosuppressed Liver Transplant Recipient
per: Catherine Zilberg, et al.
Publicat: (2022-05-01)

Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study
per: Andreas Krisl, et al.
Publicat: (2020-12-01)

Tacrolimus-Based Immunosuppressive Therapy Influences Sex Hormone Profile in Renal-Transplant Recipients—A Research Study
per: Dagmara Szypulska-Koziarska, et al.
Publicat: (2021-07-01)

Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor–free, Belatacept Plus Everolimus–based Immunosuppression
per: V. Ram Peddi, MD, et al.
Publicat: (2023-02-01)

Predictors of cancer risk in the long-term solid-organ transplant recipient.
per: Sherston, SN, et al.
Publicat: (2014)

Psychosocial Variables Associated with Immunosuppressive Medication Non-Adherence after Renal Transplantation
per: Jennifer Felicia Scheel, et al.
Publicat: (2018-02-01)